Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study.

Cardiovasc Diabetol · 2023 · PMC10303335 · PMID 37381019

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

However, GLP-1RA therapy tended to be more effective in the ARR of 3P-MACE than SGLT-2i therapy, with borderline significance in the younger age group (Supplementary Figure S6).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.